At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
DRTS Alpha Tau Medical
Closed 09-21 16:00:00 EDT
15.50
+0.26
+1.71%
盘后15.47
-0.03-0.19%
19:54 EDT
High15.59Low15.10Vol412.75K
Open15.48D1 Closing15.24Amplitude3.21%
Mkt Cap1.43BTradable Cap988.81MTotal Shares92.33M
T/O6.35MT/O Rate0.65%Tradable Shares63.79M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Alpha Tau Medical is Maintained at Overweight by Barclays
Dow Jones  ·  09-03
Alpha Tau Medical is Maintained at Overweight by Barclays
Alpha Tau price target raised to $30 from $17 at Barclays
TIPRANKS  ·  09-03
Alpha Tau price target raised to $30 from $17 at Barclays
Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (PHR), Alpha Tau (DRTS) and Fortrea Holdings Inc. (FTRE)
TIPRANKS  ·  09-03
Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (PHR), Alpha Tau (DRTS) and Fortrea Holdings Inc. (FTRE)
Alpha Tau CFO Levy to Join H.C. Wainwright Global Investor Conference Fireside Chat
Reuters  ·  09-02
Alpha Tau CFO Levy to Join H.C. Wainwright Global Investor Conference Fireside Chat
Analysts Have Conflicting Sentiments on These Healthcare Companies: PROCEPT BioRobotics (PRCT), Invivyd (IVVD) and Alpha Tau (DRTS)
TIPRANKS  ·  09-01
Analysts Have Conflicting Sentiments on These Healthcare Companies: PROCEPT BioRobotics (PRCT), Invivyd (IVVD) and Alpha Tau (DRTS)
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as US, Iran Exchange Attacks
MT Newswires Live  ·  08-31
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as US, Iran Exchange Attacks
Alpha Tau Completes Enrollment in 48-Patient Impact Pancreatic Cancer Alpha DaRT Pilot Study
Reuters  ·  08-31
Alpha Tau Completes Enrollment in 48-Patient Impact Pancreatic Cancer Alpha DaRT Pilot Study
Alpha Tau Completes Patient Enrollment in Its Multicenter Impact Pancreatic Cancer Pilot Study of Alpha Dart® Following Strong Demand and Multiple Expansions
THOMSON REUTERS  ·  08-31
Alpha Tau Completes Patient Enrollment in Its Multicenter Impact Pancreatic Cancer Pilot Study of Alpha Dart® Following Strong Demand and Multiple Expansions
Top Executive Makes Notable Move in Alpha Tau Medical’s Insider Activity
TIPRANKS  ·  08-26
Top Executive Makes Notable Move in Alpha Tau Medical’s Insider Activity
Alpha Tau Medical CFO Raphi Levy Disposes of $43,058.04 in Common Shares
Reuters  ·  08-25
Alpha Tau Medical CFO Raphi Levy Disposes of $43,058.04 in Common Shares
Nano Dimension Appoints Oramed CEO Nadav Kidron to Board to Chair Strategy, Capital Allocation Committee
Reuters  ·  08-17
Nano Dimension Appoints Oramed CEO Nadav Kidron to Board to Chair Strategy, Capital Allocation Committee
Nano Dimension Appoints Nadav Kidron to Board of Directors to Chair Strategy and Capital Allocation Committee
THOMSON REUTERS  ·  08-17
Nano Dimension Appoints Nadav Kidron to Board of Directors to Chair Strategy and Capital Allocation Committee
Top Executive Makes Notable Move With Alpha Tau Medical Stock
TIPRANKS  ·  08-13
Top Executive Makes Notable Move With Alpha Tau Medical Stock
Alpha Tau Medical CFO Raphi Levy Disposes of 17,730 Shares for $248,037.74
Reuters  ·  08-13
Alpha Tau Medical CFO Raphi Levy Disposes of 17,730 Shares for $248,037.74
Alpha Tau Medical is Maintained at Buy by HC Wainwright & Co.
Dow Jones  ·  08-11
Alpha Tau Medical is Maintained at Buy by HC Wainwright & Co.
Alpha Tau price target raised to $16 from $15 at H.C. Wainwright
TIPRANKS  ·  08-11
Alpha Tau price target raised to $16 from $15 at H.C. Wainwright
Alpha Tau Medical Ltd. : H.c. Wainwright Raises Target Price to $16 from $15
THOMSON REUTERS  ·  08-11
Alpha Tau Medical Ltd. : H.c. Wainwright Raises Target Price to $16 from $15
U.S. Research Roundup-Accendra Health, Celestica, Sionna Therapeutics
Reuters  ·  08-11
U.S. Research Roundup-Accendra Health, Celestica, Sionna Therapeutics
Alpha Tau Medical Updates Investors With H1 2026 Financials in New Form 6-K Filing
TIPRANKS  ·  08-11
Alpha Tau Medical Updates Investors With H1 2026 Financials in New Form 6-K Filing
Alpha Tau Medical Q2 EPS $(0.50) Misses $(0.14) Estimate
Benzinga Earnings  ·  08-11
Alpha Tau Medical Q2 EPS $(0.50) Misses $(0.14) Estimate

Introduction

Company Name.
Alpha Tau Medical
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.
Issue price:
--